Remineralization effect of casein phosphopeptide-amorphous calcium phosphate for enamel demineralization: a system review.
- Author:
Xiaotong WANG
1
;
Nanquan RAO
1
;
Jing XIE
2
Author Information
- Publication Type:Journal Article
- Keywords: casein phosphopeptide-amorphous calcium phosphate; randomized controlled trial; system review; white spot lesion
- From: West China Journal of Stomatology 2017;35(6):629-635
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVEThis study aims to assess the remineralization effect of casein phosphopeptide (CPP)-amorphous calcium phosphate (ACP) on enamel demineralization by performing system review of randomized controlled trials (RCT) involving the treatment of enamel demineralization with CPP-ACP.
METHODSThe study was developed based on the Cochrane handbook for systematic reviews of interventions (Version 5.1.0) and included the following: search strategy, selection criteria, data extraction, and risk of bias assessment. We searched electronic databases such as PubMed, Embase, Cochrane Library, CNKI, Wanfang and VIP up to September 2016. RCT of treating enamel demineralization with CPP-ACP were included. Data extraction and domain-based risk of bias assessment were independently performed by two reviewers.
RESULTSTwelve RCTs were included. Because of the difference of experimental design and evaluation standards, the quantitative analysis can not be carried out.
CONCLUSIONSThere is no strong evidence that CPP-ACP is superior to conventional fluoride formulations in enamel remineralization. However, due to the limitations of sample size, follow-up time and study design, more high quality and large-sample RCT are needed to further verify the evidence.
